Topas Therapeutics is a clinical-stage biotechnology company transforming the field of immune tolerance with a novel antigen-specific and targeted nanoparticle technology. Our antigen-coupled nanoparticle platform harnesses the tolerogenic power of the liver to treat autoimmune diseases. Our proprietary Topas Particles Conjugates target liver sinusoidal endothelial cells, a specific type of antigen-presenting cells highly effective at inducing T cell tolerance. With a technology adjustable to a broad spectrum of disease-relevant antigens, we have established a growing and advanced clinical pipeline to induce systemic tolerance. To learn more visit https://topas-therapeutics.com/
View Top Employees from Topas Therapeutics GmbHWebsite | http://topas-therapeutics.com |
Revenue | $5.9 million |
Employees | 21 (21 on RocketReach) |
Founded | 2016 |
Address | 88 Falkenried Haus B, Hamburg, Hamburg 20251, DE |
Phone | +49 40 56081467 |
Technologies |
JavaScript,
HTML,
Font Awesome
+2 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Drug Discovery, Business Services, Biotechnology |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Topas Therapeutics GmbH employee's phone or email?
The Topas Therapeutics GmbH annual revenue was $5.9 million in 2024.
Klaus Martin is the CEO of Topas Therapeutics GmbH.
21 people are employed at Topas Therapeutics GmbH.
Topas Therapeutics GmbH is based in Hamburg, Hamburg.
The NAICS codes for Topas Therapeutics GmbH are [54171, 541, 541713, 54, 5417].
The SIC codes for Topas Therapeutics GmbH are [87, 873].